Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Clin Pharmacol Ther. 2017 Oct 16;103(6):1061–1073. doi: 10.1002/cpt.870

Table 1. Association of selected microRNA ratios and 5-year cancer recurrence rates in patients with early-stage non-small cell lung cancer.

Expression levle Discovery Validation Combined
Recurrence
(N, %)
No recurrence
(N, %)
HRa
(95% CI)
P Recurrence
(N,%)
No recurrence
(N,%)
HRa
(95% CI)
P Recurrence
(N,%)
No recurrence
(N,%)
HRa
(95%CI)
P
miR-18a/25 Low 10 (45.45) 12 (54.55) 1 8 (33.33) 16 (66.67) 1 18 (39.13) 28 (60.87) 1
High 9 (20.00) 36 (80.00) 0.27 (0.09-0.76) 1.33E-02 11 (24.44) 34 (75.56) 0.28 (0.09-0.87) 2.69E-02 20 (22.22) 70 (77.78) 0.3 (0.14-0.63) 1.55E-03
miR-18a/93 Low 9 (42.86) 12 (57.14) 1 11 (42.31) 15 (57.69) 1 20 (42.55) 27 (57.45) 1
High 9 (18.75) 39 (81.25) 0.20 (0.06-0.66) 8.03E-03 10 (21.74) 36 (78.26) 0.27 (0.1-0.76) 1.33E-02 19 (20.21) 75 (79.79) 0.3 (0.15-0.61) 9.05E-04
miR-18a/328 Low 10 (50.00) 10 (50.00) 1 11 (44.00) 14 (56.00) 1 21 (46.67) 24 (53.33) 1
High 9 (20.45) 35 (79.55) 0.17 (0.06-0.52) 1.95E-03 8 (17.78) 37 (82.22) 0.17 (0.05-0.52) 2.16E-03 17 (19.10) 72 (80.90) 0.18 (0.08-0.39) 1.04E-05
miR-19b/339-3p Low 5 (14.29) 30 (85.71) 1 6 (17.14) 29 (82.86) 1 11 (15.71) 59 (84.29) 1
High 12 (35.29) 22 (64.71) 3.42 (1.10-10.65) 3.36E-02 15 (40.54) 22 (59.46) 3.82 (1.32-11.07) 1.35E-02 27 (38.03) 44 (61.97) 3.36 (1.58-7.14) 1.65E-03
miR-17/486-5p Low 3 (13.04) 20 (86.96) 1 4 (16.00) 21 (84.00) 1 7 (14.58) 41 (85.42) 1
High 17 (33.33) 34 (66.67) 4.52 (1.02-20.16) 4.77E-02 16 (34.78) 30 (65.22) 5.26 (1.38-20.07) 1.51E-02 33 (34.02) 64 (65.98) 3.91 (1.5-10.18) 5.25E-03
miR-20a/24 Low 10 (21.74) 36 (78.26) 1 14 (26.92) 38 (73.08) 1 24 (24.49) 74 (75.51) 1
High 8 (33.33) 16 (66.67) 3.03 (1.00-9.18) 4.99E-02 8 (32.00) 17 (68.00) 3.19 (1.07-9.52) 3.76E-02 16 (32.65) 33 (67.35) 2.37 (1.12-5) 2.40E-02
miR-27a/146a Low 7 (16.67) 35 (83.33) 1 5 (15.15) 28 (84.85) 1 12 (16.00) 63 (84.00) 1
High 12 (40.00) 18 (60.00) 3.80 (1.23-11.72) 2.02E-02 16 (37.21) 27 (62.79) 4.87 (1.07-22.2) 4.10E-02 28 (38.36) 45 (61.64) 4.49 (1.87-10.75) 7.60E-04
miR-27a/324-3p Low 3 (15.00) 17 (85.00) 1 4 (15.38) 22 (84.62) 1 7 (15.22) 39 (84.78) 1
High 15 (31.91) 32 (68.09) 6.14 (1.13-33.41) 3.59E-02 16 (36.36) 28 (63.64) 4.48 (1.24-16.23) 2.22E-02 31 (34.07) 60 (65.93) 3.09 (1.25-7.59) 1.41E-02
miR-27a/331-3p Low 3 (12.50) 21 (87.50) 1 3 (12.50) 21 (87.50) 1 6 (12.50) 42 (87.50) 1
High 15 (32.61) 31 (67.39) 5.71 (1.23-26.43) 2.58E-02 17 (35.42) 31 (64.58) 12.89 (2.35-70.74) 3.25E-03 32 (34.04) 62 (65.96) 3.03 (1.22-7.52) 1.67E-02
miR-27a/339-3p Low 6 (13.33) 39 (86.67) 1 9 (21.43) 33 (78.57) 1 15 (17.24) 72 (82.76) 1
High 9 (45.00) 11 (55.00) 6.17 (1.86-20.46) 2.95E-03 10 (41.67) 14 (58.33) 7.51 (2.12-26.62) 1.79E-03 19 (43.18) 25 (56.82) 4.07 (1.87-8.87) 4.18E-04
miR-27a/484 Low 10 (19.61) 41 (80.39) 1 12 (24.00) 38 (76.00) 1 22 (21.78) 79 (78.22) 1
High 10 (41.67) 14 (58.33) 2.72 (1.07-6.93) 3.63E-02 9 (34.62) 17 (65.38) 4.63 (1.48-14.51) 8.57E-03 19 (38.00) 31 (62.00) 3.12 (1.53-6.35) 1.69E-03
miR-25/93* Low 6 (20.69) 23 (79.31) 1 11 (26.19) 31 (73.81) 1 17 (23.94) 54 (76.06) 1
High 13 (32.50) 27 (67.50) 3.98 (1.18-13.5) 2.64E-02 10 (29.41) 24 (70.59) 3.86 (1.28-11.59) 1.62E-02 23 (31.08) 51 (68.92) 2.58 (1.22-5.44) 1.31E-02
miR-30b/150 Low 6 (13.95) 37 (86.05) 1 11 (22.92) 37 (77.08) 1 17 (18.68) 74 (81.32) 1
High 9 (40.91) 13 (59.09) 8.38 (2.26-31.11) 1.48E-03 8 (34.78) 15 (65.22) 3.32 (1.06-10.34) 3.87E-02 17 (37.78) 28 (62.22) 4.97 (2.2-11.22) 1.14E-04
miR-30c/423-5p Low 7 (16.67) 35 (83.33) 1 8 (18.18) 36 (81.82) 1 15 (17.44) 71 (82.56) 1
High 8 (36.36) 14 (63.64) 3.57 (1.16-11.01) 2.69E-02 7 (33.33) 14 (66.67) 5.03 (1.28-19.68) 2.03E-02 15 (34.88) 28 (65.12) 4.24 (1.84-9.77) 6.75E-04
miR-106b/126 Low 12 (25.00) 36 (75.00) 1 9 (20.93) 34 (79.07) 1 21 (23.08) 70 (76.92) 1
High 8 (44.44) 10 (55.56) 4.34 (1.4-13.39) 1.07E-02 10 (35.71) 18 (64.29) 3.46 (1.26-9.54) 1.63E-02 18 (39.13) 28 (60.87) 3.42 (1.67-7) 7.56E-04
miR-106b/320 Low 10 (23.26) 33 (76.74) 1 12 (23.53) 39 (76.47) 1 22 (23.40) 72 (76.60) 1
High 8 (34.78) 15 (65.22) 3.44 (1.13-10.44) 2.95E-02 8 (33.33) 16 (66.67) 3.45 (1.21-9.82) 2.04E-02 16 (34.04) 31 (65.96) 2.54 (1.25-5.16) 1.01E-02
miR-142-3p/195 Low 11 (26.19) 31 (73.81) 1 12 (21.82) 43 (78.18) 1 23 (23.71) 74 (76.29) 1
High 9 (29.03) 22 (70.97) 3.98 (1.26-12.6) 1.87E-02 7 (38.89) 11 (61.11) 4.74 (1.32-17.01) 1.69E-02 16 (32.65) 33 (67.35) 2.10 (1.03-4.27) 4.09E-02
miR-142-3p/342-3p Low 9 (18.75) 39 (81.25) 1 10 (19.61) 41 (80.39) 1 19 (19.19) 80 (80.81) 1
High 11 (37.93) 18 (62.07) 3.67 (1.15-11.7) 2.80E-02 9 (42.86) 12 (57.14) 4.98 (1.52-16.27) 7.91E-03 20 (40.00) 30 (60.00) 3.81 (1.84-7.9) 3.26E-04
miR-186/342-3p Low 7 (14.58) 41 (85.42) 1 15 (27.27) 40 (72.73) 1 22 (21.36) 81 (78.64) 1
High 11 (39.29) 17 (60.71) 7.75 (2.38-25.22) 6.78E-04 9 (36.00) 16 (64.00) 3.02 (1.06-8.67) 3.93E-02 20 (37.74) 33 (62.26) 3.61 (1.77-7.37) 4.32E-04
miR-191/331-3p Low 3 (15.79) 16 (84.21) 1 5 (20.00) 20 (80.00) 1 8 (18.18) 36 (81.82) 1
High 13 (29.55) 31 (70.45) 12.95 (1.63-103.05) 1.55E-02 15 (32.61) 31 (67.39) 7.59 (1.48-38.88) 1.50E-02 28 (31.11) 62 (68.89) 2.62 (1.07-6.42) 3.44E-02
miR-151-3p/423-5p Low 12 (28.57) 30 (71.43) 1 12 (25.00) 36 (75.00) 1 24 (26.67) 66 (73.33) 1
High 3 (14.29) 18 (85.71) 0.07 (0.01-0.57) 1.23E-02 5 (21.74) 18 (78.26) 0.16 (0.04-0.74) 1.85E-02 8 (18.18) 36 (81.82) 0.40 (0.17-0.96) 4.06E-02
miR-223*/342-3p Low 7 (19.44) 29 (80.56) 1 9 (24.32) 28 (75.68) 1 16 (21.92) 57 (78.08) 1
High 13 (37.14) 22 (62.86) 4.71 (1.47-15.09) 8.98E-03 13 (32.50) 27 (67.50) 4.20 (1.47-11.98) 7.29E-03 26 (34.67) 49 (65.33) 2.39 (1.23-4.65) l.00E-02

HR, hazard ratio; CI, confidence interval.

a

Adjusted for age, sex, smoking history, clinical stage, and treatment regimen.